CompaniesByCap
ARVN
Arvinas Inc. (ARVN)
NASDAQ · Healthcare

Arvinas Inc. Revenue 2017–2025

Arvinas Inc. annual/quarterly revenue history and growth rate from 2017 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

  • Arvinas Inc. revenue for the quarter ending March 31, 2026 was 15.6 M, a 91.74% decrease year-over-year.
  • Arvinas Inc. revenue for the twelve months ending March 31, 2026 was 268.7 M, a 12.52% increase year-over-year.
  • Arvinas Inc. annual revenue for 2025 was 262.6 M, a 0.30% decrease from 2024.
  • Arvinas Inc. annual revenue for 2024 was 263.4 M, a 235.54% increase from 2023.
  • Arvinas Inc. annual revenue for 2023 was 78.5 M, a 40.26% decrease from 2022.
  • Arvinas Inc. annual revenue for 2022 was 131.4 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %

Arvinas Inc. (ARVN) — Frequently Asked Questions

Arvinas Inc. (ARVN) is a publicly traded US company. It has a market capitalization of $495M. In fiscal 2025 it reported revenue of $263M and net income of -$81M. Explore ARVN's stock price, financial statements, earnings history, margins and key ratios below.

What is Arvinas Inc.'s market cap?

Arvinas Inc. (ARVN) has a market capitalization of $495M.

What is the ARVN stock price?

ARVN trades at $6.98 (-3.19% on the day).

How much revenue does Arvinas Inc. make?

Arvinas Inc. reported revenue of $263M in fiscal 2025.

Is ARVN profitable?

In fiscal 2025, Arvinas Inc. reported net income of -$81M.